Literature DB >> 28748159

Long-term dual antiplatelet therapy and concomitant optimal medical therapy following percutaneous coronary intervention.

Giuseppe Gargiulo1,2, Marco Valgimigli1.   

Abstract

Year:  2017        PMID： 28748159      PMCID： PMC5509929          DOI： 10.21037/cdt.2017.03.10

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN： 2223-3652


× No keyword cloud information.
  28 in total

1.  Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial.

Authors:  Raffaele Piccolo; Giulia Magnani; Sara Ariotti; Giuseppe Gargiulo; Marcello Marino; Andrea Santucci; Anna Franzone; Matteo Tebaldi; Dik Heg; Stephan Windecker; Marco Valgimigli
Journal:  EuroIntervention       Date:  2017-05-15       Impact factor: 6.534

2.  A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?

Authors:  Giuseppe Gargiulo; Stephan Windecker; Pascal Vranckx; Charles Michael Gibson; Roxana Mehran; Marco Valgimigli
Journal:  Circulation       Date:  2016-12-06       Impact factor: 29.690

Review 3.  2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.

Authors:  Glenn N Levine; Eric R Bates; John A Bittl; Ralph G Brindis; Stephan D Fihn; Lee A Fleisher; Christopher B Granger; Richard A Lange; Michael J Mack; Laura Mauri; Roxana Mehran; Debabrata Mukherjee; L Kristin Newby; Patrick T O'Gara; Marc S Sabatine; Peter K Smith; Sidney C Smith
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

4.  Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.

Authors:  Dean J Kereiakes; Robert W Yeh; Joseph M Massaro; Priscilla Driscoll-Shempp; Donald E Cutlip; P Gabriel Steg; Anthony H Gershlick; Harald Darius; Ian T Meredith; John Ormiston; Jean Francois Tanguay; Stephan Windecker; Kirk N Garratt; David E Kandzari; David P Lee; Daniel I Simon; Adrian Corneliu Iancu; Jaroslaw Trebacz; Laura Mauri
Journal:  JAMA       Date:  2015-03-17       Impact factor: 56.272

5.  Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.

Authors:  Gennaro Giustino; Alaide Chieffo; Tullio Palmerini; Marco Valgimigli; Fausto Feres; Alexandre Abizaid; Ricardo A Costa; Myeong-Ki Hong; Byeong-Keuk Kim; Yangsoo Jang; Hyo-Soo Kim; Kyung Woo Park; Martine Gilard; Marie-Claude Morice; Fadi Sawaya; Gennaro Sardella; Philippe Genereux; Bjorn Redfors; Martin B Leon; Deepak L Bhatt; Gregg W Stone; Antonio Colombo
Journal:  J Am Coll Cardiol       Date:  2016-08-29       Impact factor: 24.094

6.  Association Between Duration of Dual Antiplatelet Therapy and Angiographic Multivessel Disease on Outcomes in Patients Treated With Newer-Generation Drug-Eluting Stents.

Authors:  Seung-Yul Lee; Myeong-Ki Hong; Dong-Ho Shin; Jung-Sun Kim; Byeong-Keuk Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Hyo-Soo Kim; Marco Valgimigli; Antonio Colombo; Martine Gilard; Tullio Palmerini; Gregg W Stone
Journal:  Circ Cardiovasc Interv       Date:  2016-11       Impact factor: 6.546

7.  Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey.

Authors:  Marco Valgimigli; Francesco Costa; Robert Byrne; Michael Haude; Andreas Baumbach; Stephan Windecker
Journal:  EuroIntervention       Date:  2015-05       Impact factor: 6.534

8.  Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.

Authors:  Charles D Resor; Ashwin Nathan; Dean J Kereiakes; Robert W Yeh; Joseph M Massaro; Donald E Cutlip; P Gabriel Steg; Wen-Hua Hsieh; Laura Mauri
Journal:  Circulation       Date:  2016-08-30       Impact factor: 29.690

Review 9.  Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: conceptual evolution based on emerging evidence.

Authors:  Tullio Palmerini; Gregg W Stone
Journal:  Eur Heart J       Date:  2016-01-21       Impact factor: 29.983

Review 10.  Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials.

Authors:  Giuseppe Gargiulo; Stephan Windecker; Bruno R da Costa; Fausto Feres; Myeong-Ki Hong; Martine Gilard; Hyo-Soo Kim; Antonio Colombo; Deepak L Bhatt; Byeong-Keuk Kim; Marie-Claude Morice; Kyung Woo Park; Alaide Chieffo; Tullio Palmerini; Gregg W Stone; Marco Valgimigli
Journal:  BMJ       Date:  2016-11-03
View more
  1 in total

Review 1.  Antiplatelet agents in uncertain clinical scenarios-a bleeding nightmare.

Authors:  Sean Esmonde; Divyesh Sharma; Aaron Peace
Journal:  Cardiovasc Diagn Ther       Date:  2018-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.